Decision: Favourable

Study Title:

TTRIO045/LidERA : A phase III, randomized, open-label, multicenter study evaluating the efficacy and safety of adjuvant giredestrant compared with physician’s choice of adjuvant endocrine monotherapy in patients with estrogen receptor-positive, HER2-negative, early breast cancer.

  • NREC Code:


  • Decision:


  • Meeting Date:


  • Study Type:

    CT application

  • Principal Investigator:

    Prof Janice Walshe

  • PI Institution:

    St Vincent's University Hospital

  • Sponsor:

    F. Hoffman La Roche Ltd

Scroll to Top